Neuroendocrine Role of Receptors for Insulin and IGF-1 in the Pituitary Gland: Morphological Considerations

  • J. W. Unger
  • M. Betz
  • W. Lange
Conference paper

Abstract

Previous investigations have demonstrated that interaction of peripheral insulin with neuroendocrine centers of the brain may play a key role in the regulation of body metabolism. Since the various levels of interaction are only incompletely known, the present study focused on the adenohypophysis of the rat, where the localization of the insulin receptor and the structurally and functionally closely related insulin-like growth factor-1 (IGF-1) receptor was investigated by light and electronmicroscopic immunocytochemistry. The two receptors were found on separate subpopulations of secretory cells of the pars distalis, the IGF-1 receptors preferentially occurred in the postero-lateral region, whereas insulin receptors were dispersed throughout the pars distalis. Almost 90% of cells containing insulin receptors were also shown to be immunoreactive for (β-endorphin. In contrast, IGF-1 receptors were almost exclusively located on follicle stimulating hormone secreting cells, suggesting a regulatory role of IGF-1 in the pituitary gonadotropin system. In addition, key proteins of receptor tyrosine kinase signal transduction, such as insulin receptor substrate-1 and phosphatidyl inositol-3 kinase, were demonstrated in the anterior lobe. Both markers were highly colocalized in two populations of morphologically distinct secretory cells, i.e. large, smooth-shaped cells and small-sized cells with irregular cytoplasmic protrusions. These data indicate the ability of insulin and IGF-1 receptors to transduce biological signals in the pituitary in vivo and further support the hypothesis that peripheral insulin acts as a regulatory hormone in the control of body homeostasis via various steps in the neuroendocrine axis, including the pituitary gland.

Keywords

Estrogen Tyrosine Cytosol Glucagon Glutaraldehyde 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baskin DG, Figlewicz DP, Woods SC, Porte D jr, Dorsa DM (1987) Insulin in the brain. Annu Rev Physiol 49: 335–347PubMedCrossRefGoogle Scholar
  2. Baskin DG, Sipols AJ, Schwartz MW, White MF (1993) Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine. Regul Peptides 48: 257–266CrossRefGoogle Scholar
  3. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L, Hintz RL (1981) Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212: 1279–1281PubMedCrossRefGoogle Scholar
  4. Blasquez C, Jégou S, Friard O, Tonon MC, Fournier A, Vaudry H (1995) Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal pro-opiomelanocortin-derived peptides in the rat. Neuroscience 68: 221–227PubMedCrossRefGoogle Scholar
  5. Bohannon NJ, Corp ES, Wilcox BJ, Figlewicz DP, Dorsa DM, Baskin DG (1988) Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res 444: 205–213PubMedCrossRefGoogle Scholar
  6. Cusin I, Dryden S, Wang Q, Rohner-Jeanrenaud F, Jeanrenaud B, Williams G (1995) Effects of sustained physiological hyperinsulinemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat. Neuroendocrinology 7: 193–197CrossRefGoogle Scholar
  7. Dalayeun JF, Nores JM, Bergal S (1993) Physiology of β-endorphins. A close-up view and a review of the literature. Biomed Pharmacother 47: 311–320PubMedCrossRefGoogle Scholar
  8. De Keyser J, Wilczak N, De Backer J-P, Herroelen L, Vauquelin G (1994) Insulin-like growth factor-I receptors in human brain and pituitary gland: an autoradiographic study. Synapse 17: 196–202PubMedCrossRefGoogle Scholar
  9. D’Ercole AJ, Stiles AD, Underwood LE (1984) Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine and autocrine mechanisms of action. Proc Natl Acad Sci USA 81: 935–939PubMedCrossRefGoogle Scholar
  10. Endemann G, Yonezawa K, Roth RA (1990) Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem 265: 396–400PubMedGoogle Scholar
  11. Folli F, Saad MJA, Kahn CR (1996) Insulin receptor/IRS-l/PI 3-kinase signalling system in corticosteroid-induced insulin resistance. Acta Diabetologia 33: 185–192CrossRefGoogle Scholar
  12. Goldstein BJ, Dudley AL (1990) The rat insulin receptor: primary structure and conservation of tissue-specific alternative messenger RNA splicing. Mol Endocrinol 2: 235–244CrossRefGoogle Scholar
  13. Grossman SP (1986) The role of glucose, insulin and glucagon in the regulation of food intake and body weight. Neurosci Behav Rev 10: 295–315CrossRefGoogle Scholar
  14. Hayashi H, Miyake N, Kanai F, Shibasaki F, Takenawa T, Ebina Y (1991) Phosphorylation in vitro of the 85kDa subunit of phosphatidylinositol 3-kinase and its possible activation by insulin receptor tyrosine kinase. Biochem J 280: 769–775PubMedGoogle Scholar
  15. Häring HU (1991) The insulin receptor: signalling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia 34: 848–861PubMedCrossRefGoogle Scholar
  16. Johnson RD (1995) Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders. Medical Hypothesis 45: 491–497CrossRefGoogle Scholar
  17. Kanematsu T, Irahara M, Miyake T, Shitsukawa K, Aono T (1991) Effect of insulin-like growth factor-I on gonadotropin release from the hypothalamus-pituitary axis in vitro. Acta Endocrinol 125: 227–233PubMedGoogle Scholar
  18. Kennedy GC (1953) The role of depot fat in the hypothalamic control of food intake in the rat. Proc R Soc Lond (Biol) 140: 579–592CrossRefGoogle Scholar
  19. Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ (1995) Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. J Clin Invest 96: 163–170PubMedCrossRefGoogle Scholar
  20. Lamphere L, Lienhard GE (1992) Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubes. Endocrinology 131: 2196–2202PubMedCrossRefGoogle Scholar
  21. Lavan BE, Lienhard GE (1993) The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. J Biol Chem 268: 5921–5928PubMedGoogle Scholar
  22. Leibowitz SF (1992) Neurochemical-neuroendocrine systems in the brain controlling macronutrient intake and metabolism. TINS 15: 491–497PubMedGoogle Scholar
  23. Lesniak MA, Hill JA, Kiess W, Rojeski M, Pert CB, Roth J (1988) Receptors for IGF-I and -II: autoradiographic localization in the rat brain and comparison to receptors for insulin. Endocrinology 123: 2089–2099PubMedCrossRefGoogle Scholar
  24. Levine AS, Morley JE, Gosnell BA, Billington CJ, Bartness TJ (1985) Opioids and consummatory behaviour. Brain Res Bull 14: 663–672PubMedCrossRefGoogle Scholar
  25. Livingston JN, Unger JW (1992) Immunohistochemical localization and biochemical analysis of tyrosine kinases in the central nervous system. Neuroprotocols 1: 193–200CrossRefGoogle Scholar
  26. McElduff A, Poronnik P, Baxter RC, Williams P (1988) A comparison of the insulin and insulinlike growth factor I receptors from rat brain and liver. Endocrinology 122: 1933–1939PubMedCrossRefGoogle Scholar
  27. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA (1993) Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 132: 23–29PubMedCrossRefGoogle Scholar
  28. Myers MG, Sun XJ, White MF (1994) The IRS-1 signalling system. TIBS 19: 289–293PubMedGoogle Scholar
  29. Noguchi T, Sugisaki T, Kanamatsu T, Nishikawa N (1989) Presence of an insulin-like growth factor I (somatomedin C) immunoreactive substance in GH producing cells in the bovine anterior pituitary. Horm Metabol Res 12: 165–167CrossRefGoogle Scholar
  30. Ramabadran K, Bansinath M (1990) Glucose homeostasis and endogenous opioid peptides. Int J Clin Pharamacol Ther Toxicol 28: 89–98Google Scholar
  31. Rordorf-Nikolic T, VanHorn DJ, Chen D, White MF, Backer JM (1995) Regulation of phosphatidylinositol 3’-kinase by tyrosyl phosphoproteins. J Biol Chem 270: 3662–3666PubMedCrossRefGoogle Scholar
  32. Rosenfeld RG, Ceda G, Wilson DM, Dollar LA, Hoffmann AR (1984) Characterization of high affinity receptors for insulin-like growth factors I and II on rat anterior pituitary cells. Endocrinology 114: 1571–1575PubMedCrossRefGoogle Scholar
  33. Rothenberg PL, Lane WS, Karasik A, Backer J, White MF, Kahn CR (1991) Purification and partial sequence analysis of ppl85, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266: 8302–8311PubMedGoogle Scholar
  34. Sandberg A-C, Engberg C, Lake M, von Hoist H, Sara VR (1988) The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 93: 114–119PubMedCrossRefGoogle Scholar
  35. Schick RR, Schusdziarra V, Nussbaumer C, Classen M (1991) Neuropeptide Y and food intake in fasted rats: effect of naloxone and site of action. Brain Res 552: 232–239PubMedCrossRefGoogle Scholar
  36. Schick RR, Samsami S, Zimmermann JP, Eberl Th, Endres C, Schusdziarra V, Classen M (1993) Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. Am J Physiol 264: R355-R361Google Scholar
  37. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D jr (1992a) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13: 387–414PubMedGoogle Scholar
  38. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP, Porte D jr (1992b) Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130: 3608–3616PubMedCrossRefGoogle Scholar
  39. Shemer J, Adamo M, Wilson GL, Heffez D, Zick Y, LeRoith D (1987) Insulin and insulin-like growth factor-I stimulate a common endogenous phosphoprotein substrate (ppl85) in intact neuroblastoma cells. J Biol Chem 262: 15476–15482PubMedGoogle Scholar
  40. Shia MA, Pilch PF (1983) The (β-subunit of the insulin receptor is an insulin-activated proteinkinase. Biochemistry 22: 717–721PubMedCrossRefGoogle Scholar
  41. Shoelson SE, Chatterjee S, Chaudhuri M, White MF (1992) YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc. Natl. Acad. Sci. USA 89: 2027–2031PubMedCrossRefGoogle Scholar
  42. Soldani R, Cagnacci A, Yen SS (1994) Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131: 641–645PubMedCrossRefGoogle Scholar
  43. Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189–1192PubMedCrossRefGoogle Scholar
  44. Sternberger LA (1979) Immunocytochemistry, 2nd edn. Wiley, New YorkGoogle Scholar
  45. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73–77PubMedCrossRefGoogle Scholar
  46. Ullrich A, Bell JR, Chen E, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao Y-C, Tsubokawa M, Mason A, Seeburg PH, Greenfeld C, Rosen OM, Ramachandran J (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756–761PubMedCrossRefGoogle Scholar
  47. Ullrich A, Gray A, Tam AW, Yang-Zeng T, Tsubokawa M, Collina C, Henzel W, LeBon T, Kathuria S, Chen E, Jacobs S, Frabcke U, Ramachandran J, Fujita-Yamaguchi Y (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5: 2503–2512PubMedGoogle Scholar
  48. Unger J, McNeill TH, Moxley III RT, White M, Moss AM, Livingston JN (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31: 143–157PubMedCrossRefGoogle Scholar
  49. Unger JW, Livingston JN, Moss AM (1991) Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Progr Neurobiol 36: 343–362CrossRefGoogle Scholar
  50. Unger JW, Moss AM, Livingston JN (1993) The pars tuberalis is enriched with distinct phosphotyrosine-containing proteins not detected in other areas of the brain and pituitary. Cell Tissue Res 272: 499–507PubMedCrossRefGoogle Scholar
  51. Unger JW, Lange W (1997) Insulin receptors in the pituitary gland: morphological evidence for influence on opioid peptide-synthesizing cells. Cell Tissue Res 288: 471–483PubMedCrossRefGoogle Scholar
  52. Van Houten M, Posner BI, Kopriwer BM, Brawer JR (1980) Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science 207: 1081–1083PubMedCrossRefGoogle Scholar
  53. Waters SB, Pessin JE (1996) Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave. Trends Cell Biol 6: 1–4PubMedCrossRefGoogle Scholar
  54. Waters SB, Yamauchi K, Pessin JE (1993) Functional expression of insulin receptor substrate-1 is required for insulin-stimulated mitogenic signaling. J Biol Chem 268: 22231–22234PubMedGoogle Scholar
  55. Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, Mendelsohn FAO (1987) Localization and characterization of insulin receptors in the rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121: 1562–1570PubMedCrossRefGoogle Scholar
  56. Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Mendelsohn FAO (1989) Localization and characterization of IGF-I receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry: a distinct distribution from insulin receptors. J Neuroendocrinol 1: 369–377PubMedCrossRefGoogle Scholar
  57. White MF, Maron R, Kahn CR (1985) Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318: 183–186PubMedCrossRefGoogle Scholar
  58. White MF, Kahn CR (1989) Cascade of autophosphorylation in the beta-subunit of the insulin receptor. J Cell Biochem 39: 429–441PubMedCrossRefGoogle Scholar
  59. Whitley NC, Barb CR, Utley RV, Popvell JM, Kraeling RR, Rampacek GB (1995) Influence of stage of the estrous cycle on insulin-like growth factors-I modulation of luteinizing hormone secretion in the gilt. BioÍ Reprod 53: 1359–1364CrossRefGoogle Scholar
  60. Woods SC, Porte D jr, Bobbioni E, Ionescu E, Sauter J-F, Rohner-Jeanrenaud F, Jeanrenaud B (1985) Insulin: its relationship to the central nervous system and control of food intake and body weight. Am J Clin Nutr 42: 1063–1071PubMedGoogle Scholar
  61. Yamashita S, Melmed S (1986) IGF-I action on rat anterior pituitary cells: suppression of growth hormone secretion and mRNA levels. Endocrinology 118: 176–182PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. W. Unger
    • 1
  • M. Betz
    • 1
  • W. Lange
    • 1
  1. 1.Department of AnatomyUniversity of MunichMünchenGermany

Personalised recommendations